Department of Radiology
Found 9 results
Filters: Author is Zu, Youli  [Clear All Filters]
2020
Zeng Z, Tung C-H, Zu Y.  2020.  Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy.. Cancers (Basel). 12(4)
2015
Zhao N, Pei S-N, Qi J, Zeng Z, Iyer SP, Lin P, Tung C-H, Zu Y.  2015.  Oligonucleotide aptamer-drug conjugates for targeted therapy of acute myeloid leukemia.. Biomaterials. 67:42-51.
2014
Zeng Z, Tung C-H, Zu Y.  2014.  A cancer cell-activatable aptamer-reporter system for one-step assay of circulating tumor cells.. Mol Ther Nucleic Acids. 3:e184.
Zeng Z, Parekh P, Li Z, Shi Z-Z, Tung C-H, Zu Y.  2014.  Specific and sensitive tumor imaging using biostable oligonucleotide aptamer probes.. Theranostics. 4(9):945-52.
2012
Zhao N, Qi J, Zeng Z, Parekh P, Chang C-C, Tung C-H, Zu Y.  2012.  Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.. J Control Release. 159(1):104-10.
2010
Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ et al..  2010.  Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition.. Leuk Res. 34(1):85-92.
Zeng Z, Zhang P, Zhao N, Sheehan AM, Tung C-H, Chang C-C, Zu Y.  2010.  Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues.. Mod Pathol. 23(12):1553-8.
2009
Zhang P, Zhao N, Zeng Z, Feng Y, Tung C-H, Chang C-C, Zu Y.  2009.  Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells.. Lab Invest. 89(12):1423-32.
2008
Wen J, Cheng HY, Feng Y, Rice L, Liu S, Mo A, Huang J, Zu Y, Ballon DJ, Chang C-C.  2008.  P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells.. Br J Haematol. 140(2):169-80.